hrp0084p2-421 | GH & IGF | ESPE2015

Application of Neural Networks for Final Height Prediction Based on Pre-Treatment Data in Children with GH Deficiency Treated with GH

Smyczynska Joanna , Smyczynska Urszula , Stawerska Renata , Lewinski Andrzej , Tadeusiewicz Ryszard , Hilczer Maciej

Background: Prediction of the effectiveness of GH therapy in children with short stature is an important issue. Artificial neural networks (ANN) seem to be promising tool for this purpose, not requiring any assumption on functions linking independent and dependent variables.Objective and hypotheses: The aim of the study was to compare ANN models of GH therapy effectiveness, based on the data available at therapy onset with multiple linear regression (MLR...

hrp0084p2-561 | Thyroid | ESPE2015

Analysis of Chosen Polymorphisms rs5742909 C/T – CTLA4, rs7522061 C/T – FCRL3, rs7138803 A/G – FAIM2 in Pathogenesis of Autoimmune Thyroid Diseases in Children

Jakubowska Ewa , Goscik Joanna , Wawrusiewicz-Kurylonek Natalia , Bossowska Anna , Kretowski Adam , Bossowski Artur

Background: Autoimmune thyroid diseases are multifactorial diseases with a genetic susceptibility and environmental factors. A potential role of cytotoxic T-lymphocyte-associated protein 4 (CTLA4) gene, Fc receptor-like 3 (FCRL3) gene, Fas apoptotic inhibitory molecule 2 (FAIM2) gene polymorphisms on autoimmune thyroid diseases (AITDs) in children has not been established equivocally yet.Objective and hypotheses: To estimate the association of polymorphi...

hrp0084p3-826 | Endocrine Oncology | ESPE2015

The Evaluation of Bone Mass Density in Patients after Therapy of Solid Tumours

Polubok Joanna , Jasielska Olimpia , Gonera Aleksandra , Kozicka Marta , Dubienska Katarzyna , Kazanowska Bernarda , Barg Ewa

Backgrounds and objectives: Low bone mass density is an important problem in survivors of childhood cancers. The aim of this study is to determinate the influence of factors on bone mass density (BMD) and the prevalence of abnormal bone turnover.Materials and methods: The evaluation was performed in 67 patients (64.18% boys and 35.82% girls) at least 1 year after therapy of solid tumours, aged 4–27 years (median 12.67). The following parameters were...

hrp0084p3-862 | Fat | ESPE2015

Diagnosis and Treatment of Familial Hypercholesterolemia in Children – A Preliminary Report

Brandt Agnieszka , Bautembach-Minkowska Joanna , Hennig Matylda , Waseg Bartosz , Limon Janusz , Mysliwiec Malgorzata

Background: Heterozygous familial hypercholesterolemia (FH) is an autosomal dominant genetic disorder occuring in 1:500 people. Patients with FH have a high risk of premature cardiovascular diseases. Today effective lipid-lowering therapies are available and it is a chance to extend the life of patients.Aims and objectives: The aim was to analyse the clinical data of children with FH from the Clinic of Pediatrics, Diabetology and Endocrinology and prelim...

hrp0094p1-174 | Growth Hormone and IGFs B | ESPE2021

High incidence and male predominance of transient form of isolated growth hormone (GH) deficiency in children. What is the optimal time for GH therapy withdrawal and retesting?

Smyczyńska Joanna , Hilczer Maciej , Lewiński Andrzej , Smyczyńska Urszula , Stawerska Renata ,

Introduction: Normal growth hormone (GH) secretion after the attainment of final height (FH) is observed in the majority of GH-treated children with GH deficiency (GHD), however it is unclear when such normalization of GH secretion occurs.The Aim: Of the study was to assess the incidence of transient GHD in retesting with respect to pediatric criteria in the patients with isolated GHD diagnosed in childhood, depending on the moment of GH...

hrp0094p2-282 | Growth and syndromes (to include Turner syndrome) | ESPE2021

Brain-derived neurotrophic factor and matrix metalloproteinases as markers of metabolic status in girls with Turner syndrome.

Błaszczyk Ewa , Gawlik Jakub , Gieburowska Joanna , Tokarska Agnieszka , Francuz Tomasz , Gawlik Aneta ,

Background: Turner syndrome (TS) predisposes to obesity and related metabolic disorders and presents a high risk of congenital heart defects. Growth hormone (GH) treatment used in TS girls also affects the parameters of carbohydrate-lipid metabolism. Thus, the search for new markers that could be early predictors of metabolic disorders seems to be justified.Objective and Method: The assessment and comparison of MMP-1, MMP-2, MMP-9 (matri...

hrp0097p1-436 | Diabetes and Insulin | ESPE2023

Should the diagnostic criteria of childhood obesity depend on the nutritional status of national pediatric population? A lesson form assessment of Ukrainian children with type 1 diabetes in Poland after Russian aggression against Ukraine.

Smyczyńska Joanna , Suchowiński Michał , Kopeć Kacper , Seliga Przemysław , Olejniczak Aleksandra , Szadkowska Agnieszka

Introduction: Childhood overnutrition is a global challenge of public health. Both WHO and different countries have prepared BMI charts for pediatric population. Proper assessment of nutritional status is particularly important in children with type 1 diabetes (DM1). Due to Russian aggression, some Ukrainians with DM1 have to continue treatment in Poland.Aim: to compare HbA1 concentrations and the incidence of overnutrit...

hrp0097p1-537 | Multisystem Endocrine Disorders | ESPE2023

Effects of seasonal variability of insolation and COVID-19 pandemic isolation on vitamin D concentrations in children

Smyczyńska Joanna , Hilczer Maciej , Łupińska Anna , Pawelak Natalia , Lewiński Andrzej , Stawerska Renata

Introduction: Vitamin D may be considered as a hormone of prohormone of pleiotropic effects. Seasonal variability of insolation affects its synthesis in humans. In our latitude, vitamin D deficiency is widespread. In 2018, updated recommendations for vitamin D supplementation were published in Poland by Rusi&nacute;ska et al. In 2020, SARS-CoV-2 pandemic lockdown was introduced, with suggestions of protective anti-viral vitamin D role.<p class="ab...

hrp0097p2-59 | Bone, Growth Plate and Mineral Metabolism | ESPE2023

Serum levels of carboxylated and undercarboxylated osteocalcin in non-obese children with Prader-Willi syndrome

Gajewska Joanna , Chełchowska Magdalena , Klemarczyk Witold , Strucińska Małgorzata , Ambroszkiewicz Jadwiga

Introduction: Prader-Willi syndrome (PWS) is a rare congenital neurodevelopmental disorder characterized by hyperphagia, growth hormone (GH) deficiency, short stature, and low bone mineral density. The mechanisms concerning bone metabolism disturbances in these patients are still unclear. An important role in the process of bone formation is played by osteocalcin (OC), the most abundant non-collagen protein of the bone matrix. OC has three potential gamma-carb...

hrp0095p1-113 | Growth and Syndromes | ESPE2022

Development and testing of a novel ‘GrowthMonitor’ Smartphone App for growth monitoring and the detection of growth disorders

Thaventhiran Thilipan , Orr Joanna , K. Morris Joan , Harding Vincent , Hsu Ann , Dunkel Leo , Chapple Paul , L. Storr Helen

Background: Childhood growth is an indicator of health/well-being. Growth monitoring identifies treatable conditions in apparently healthy children and prevents inappropriate referrals. Systematic growth monitoring is not currently a UK priority and growth disorders are frequently diagnosed late.Objective: Develop and test the accuracy of GrowthMonitor, an app which enables families to measure a child’s height at h...